Literature DB >> 21098038

Quantitative analysis of ERK2 interactions with substrate proteins: roles for kinase docking domains and activity in determining binding affinity.

Kimberly A Burkhard1, Fengming Chen, Paul Shapiro.   

Abstract

Extracellular signal-regulated kinase-1 and -2 (ERK1/2) proteins regulate a variety of cellular functions, including cell proliferation and differentiation, by interacting with and phosphorylating substrate proteins. Two docking sites, common docking (CD/ED) domain and F-site recruitment site (FRS), on ERK proteins have been identified. Specific interactions with the CD/ED domain and the FRS occur with substrates containing a docking site for ERK and JNK, LXL (DEJL) motif (D-domain) and a docking site for ERK, FXF (DEF) motif (F-site), respectively. However, the relative contributions of the ERK docking sites in mediating substrate interactions that allow efficient phosphate transfer are largely unknown. In these studies, we provide a quantitative analysis of ERK2 interactions with substrates using surface plasmon resonance to measure real time protein-protein interactions. ERK2 interacted with ELK-1 (DEF and DEJL motifs), RSK-1 (DEJL motif), and c-Fos (DEF motif) with K(D) values of 0.25, 0.15, and 0.97 μM, respectively. CD/ED domain mutations inhibited interactions with ELK-1 and RSK-1 by 6-fold but had no effect on interactions with c-Fos. Select mutations in FRS residues differentially inhibited ELK-1 or c-Fos interactions with ERK2 but had little effect on RSK-1 interactions. Mutations in both the ED and FRS docking sites completely inhibited ELK-1 interactions but had no effect on interactions with stathmin, an ERK substrate whose docking site is unknown. The phosphorylation status of ERK2 did not affect interactions with RSK-1 or c-Fos but did inhibit interactions with ELK-1 and stathmin. These studies provide a quantitative evaluation of specific docking domains involved in mediating interactions between ERK2 and protein substrates and define the contributions of these interactions to phosphate transfer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21098038      PMCID: PMC3024742          DOI: 10.1074/jbc.M110.177899

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Docking interactions induce exposure of activation loop in the MAP kinase ERK2.

Authors:  Tianjun Zhou; Liguang Sun; John Humphreys; Elizabeth J Goldsmith
Journal:  Structure       Date:  2006-06       Impact factor: 5.006

2.  Mechanisms of MAPK signalling specificity.

Authors:  L Bardwell
Journal:  Biochem Soc Trans       Date:  2006-11       Impact factor: 5.407

Review 3.  Unique MAP Kinase binding sites.

Authors:  Radha Akella; Thomas M Moon; Elizabeth J Goldsmith
Journal:  Biochim Biophys Acta       Date:  2007-11-19

4.  Dynamics of the Ras/ERK MAPK cascade as monitored by fluorescent probes.

Authors:  Aki Fujioka; Kenta Terai; Reina E Itoh; Kazuhiro Aoki; Takeshi Nakamura; Shinya Kuroda; Eisuke Nishida; Michiyuki Matsuda
Journal:  J Biol Chem       Date:  2006-01-17       Impact factor: 5.157

Review 5.  Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Ellis W T Wong; Fumin Chang; Brian Lehmann; David M Terrian; Michele Milella; Agostino Tafuri; Franca Stivala; Massimo Libra; Jorg Basecke; Camilla Evangelisti; Alberto M Martelli; Richard A Franklin
Journal:  Biochim Biophys Acta       Date:  2006-10-07

Review 6.  Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.

Authors:  P J Roberts; C J Der
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

7.  The anti-apoptotic protein PEA-15 is a tight binding inhibitor of ERK1 and ERK2, which blocks docking interactions at the D-recruitment site.

Authors:  Kari Callaway; Olga Abramczyk; Lance Martin; Kevin N Dalby
Journal:  Biochemistry       Date:  2007-07-21       Impact factor: 3.162

8.  Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy.

Authors:  Bret B Friday; Alex A Adjei
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531

9.  Calcium-mediated interactions regulate the subcellular localization of extracellular signal-regulated kinases.

Authors:  Dana Chuderland; Goldie Marmor; Alla Shainskaya; Rony Seger
Journal:  J Biol Chem       Date:  2008-02-11       Impact factor: 5.157

10.  The docking interaction of caspase-9 with ERK2 provides a mechanism for the selective inhibitory phosphorylation of caspase-9 at threonine 125.

Authors:  Morag C Martin; Lindsey A Allan; Erika J Mancini; Paul R Clarke
Journal:  J Biol Chem       Date:  2007-12-14       Impact factor: 5.157

View more
  29 in total

1.  Constitutive K-RasG12D activation of ERK2 specifically regulates 3D invasion of human pancreatic cancer cells via MMP-1.

Authors:  Gregory P Botta; Mauricio J Reginato; Maximilian Reichert; Anil K Rustgi; Peter I Lelkes
Journal:  Mol Cancer Res       Date:  2011-12-08       Impact factor: 5.852

2.  Examining docking interactions on ERK2 with modular peptide substrates.

Authors:  Sunbae Lee; Mangalika Warthaka; Chunli Yan; Tamer S Kaoud; Pengyu Ren; Kevin N Dalby
Journal:  Biochemistry       Date:  2011-10-18       Impact factor: 3.162

3.  Identification of direct tyrosine kinase substrates based on protein kinase assay-linked phosphoproteomics.

Authors:  Liang Xue; Robert L Geahlen; W Andy Tao
Journal:  Mol Cell Proteomics       Date:  2013-06-22       Impact factor: 5.911

4.  Quantitative in vivo fluorescence cross-correlation analyses highlight the importance of competitive effects in the regulation of protein-protein interactions.

Authors:  Wakako Sadaie; Yoshie Harada; Michiyuki Matsuda; Kazuhiro Aoki
Journal:  Mol Cell Biol       Date:  2014-06-23       Impact factor: 4.272

5.  Functional divergence caused by mutations in an energetic hotspot in ERK2.

Authors:  Clinton A Taylor; Kevin W Cormier; Shannon E Keenan; Svetlana Earnest; Steve Stippec; Chonlarat Wichaidit; Yu-Chi Juang; Junmei Wang; Stanislav Y Shvartsman; Elizabeth J Goldsmith; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-11       Impact factor: 11.205

6.  Single-cell quantification of the concentrations and dissociation constants of endogenous proteins.

Authors:  Akira T Komatsubara; Yuhei Goto; Yohei Kondo; Michiyuki Matsuda; Kazuhiro Aoki
Journal:  J Biol Chem       Date:  2019-02-09       Impact factor: 5.157

7.  Mapping the binding interface of ERK and transcriptional repressor Capicua using photocrosslinking.

Authors:  Alan S Futran; Saw Kyin; Stanislav Y Shvartsman; A James Link
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

Review 8.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

9.  Growth arrest signaling of the Raf/MEK/ERK pathway in cancer.

Authors:  Jong-In Park
Journal:  Front Biol (Beijing)       Date:  2014-02

10.  Specificity of linear motifs that bind to a common mitogen-activated protein kinase docking groove.

Authors:  Ágnes Garai; András Zeke; Gergő Gógl; Imre Törő; Ferenc Fördős; Hagen Blankenburg; Tünde Bárkai; János Varga; Anita Alexa; Dorothea Emig; Mario Albrecht; Attila Reményi
Journal:  Sci Signal       Date:  2012-10-09       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.